MMA MIXED MARTIAL ARTS GROUP LTD

NEUTRAL Impact: 4/10 6-K
Horizon weeks Filed May 12, 2026 Processed 1mo ago SEC 0001493152-26-022412
Notable filing: 6-K
Latest settled — T+5d
MMA ▼ -3.94% at T+5d
NEUTRAL call ✗ call lost -3.94% · α vs SPY -4.02% · entry $0.5580 → $0.5360
Next anchor: T+20d due 3d ago
Currently $0.4370 · -21.68% from $0.5580 entry
Entry anchored
May 11, 03:55 PM ET
via Databento tick
T+1d
-2.15%
call -2.15% · α -2.73%
$0.5460
settled 4w ago
T+5d
-3.94%
call -3.94% · α -4.02%
$0.5360
settled 25d ago
T+20d
call — · α —
due 3d ago
T+60d
call — · α —
in 8w

Price Chart

Loading chart...

Executive Summary

MMA.INC announced an exclusive strategic marketing partnership with Precision Peptide Company Inc. (CSE: BPC) to market peptide recovery products across its global combat sports ecosystem. Under the agreement, MMA will receive 50% of net revenue from MMA-sourced sales in year one and 25% thereafter, with no capital investment required. The partnership provides a new revenue vertical but no financial projections or current revenue figures were disclosed.

Actionable Insight

This is a non-capital-intensive revenue-sharing agreement with no disclosed financial projections. Monitor future filings for initial sales data and commercialization updates to assess revenue contribution. The partnership is terminable on 30 days' notice, limiting downside risk but also signaling low commitment.

Key Facts

  • Exclusive partnership with Precision Peptide Company Inc. (CSE: BPC) for peptide recovery products
  • MMA receives 50% of net revenue from MMA-sourced sales in year 1, then 25% for remainder of term
  • No capital investment required from MMA
  • Products are U.S. manufactured and third-party tested
  • MMA ecosystem includes ~530,000 user profiles, 75,000+ active students, 800+ verified gyms globally
  • Partnership may be terminated by either party upon 30 days' written notice
  • 12-month tail period for revenue share after termination/expiration

Financial Impact

No revenue or financial projections provided; revenue share structure is 50/25% of net revenue from MMA-sourced sales, but no baseline or forecast given

revenue

Risk Factors

  • No financial projections or revenue guidance provided; actual revenue contribution uncertain
  • Partnership terminable on 30 days' notice, indicating potential instability
  • Peptide market regulatory risks and compliance requirements
  • MMA's small market cap ($14M) makes even modest revenue streams potentially material

Market Snapshot

Exchange
NYSE
Sector
Services-Miscellaneous Business Services

Documents Analyzed

This report is based on 5 SEC documents filed with EDGAR.

DocumentAccession Number
6-K Filing (Primary)0001493152-26-022412
Document: form6-k.htm0001493152-26-022412
Document: 0001493152-26-022412-index-headers.html0001493152-26-022412
Document: 0001493152-26-022412-index.html0001493152-26-022412
Document: 0001493152-26-022412.txt0001493152-26-022412
11 reports for MMA
Performance horizon
75% Hit rate 3 of 4 directional calls best @ T+20▲ +42.86%Apr 1, 2026
Filters
Rows
Reports for MMA — sortable, filterable
Type Now
Jun 1, 2026
12d ago
6-K
NEUTRAL ★ 4/10
$0.5740 $0.5740· 0.00%▲ +2.75%$0.4370 (−23.87%)
May 12, 2026
4w ago
6-K
NEUTRAL ★ 4/10
$0.5580 $0.5360▼ −3.94%▼ −4.02%$0.4370 (−21.68%)
May 6, 2026
5w ago
6-K
BULLISH ★ 5/10
$0.5700 $0.5580▼ −2.11%▼ −3.24%$0.4370 (−23.33%)
Apr 29, 2026
6w ago
6-K
NEUTRAL ★ 3/10
$0.6600 $0.5500▼ −16.67%▼ −19.78%$0.4370 (−33.79%)
Apr 23, 2026
7w ago
6-K
BULLISH ★ 7/10
$0.7360 $0.6600▼ −10.33%▼ −11.80%$0.4370 (−40.62%)
Apr 22, 2026
7w ago
6-K
BULLISH ★ 6/10
$0.7290 $0.6324▼ −13.25%▼ −13.31%$0.4370 (−40.05%)
Apr 21, 2026
7w ago
6-K
NEUTRAL ★ 3/10
$0.6230 $0.6500▲ +4.33%▲ +3.25%$0.4370 (−29.86%)
Apr 16, 2026
8w ago
6-K
NEUTRAL ★ 4/10
$0.5030 $0.7360▲ +46.32%▲ +45.34%$0.4370 (−13.12%)
Apr 15, 2026
8w ago
6-K
NEUTRAL ★ 3/10
$0.5130 $0.7290▲ +42.11%▲ +40.47%$0.4370 (−14.81%)
Apr 1, 2026
10w ago
6-K
BULLISH ★ 7/10
$0.4620 $0.4220▼ −8.66%▼ −12.42%$0.4370 (−5.41%)
Showing 10 of 11

US Market Status

Market Closed — Opens Mon (48h 50m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access